Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark Lefever is active.

Publication


Featured researches published by Mark Lefever.


Laboratory Investigation | 2017

Fully automated 5-plex fluorescent immunohistochemistry with tyramide signal amplification and same species antibodies.

Wenjun Zhang; Antony Hubbard; Tobin Jones; Adriana Racolta; Srabani Bhaumik; Nick Cummins; Liping Zhang; Karl Garsha; Frank Ventura; Mark Lefever; Zhenqiang Lu; John K. Hurley; William Day; Lidija Pestic-Dragovich; Larry Morrison; Lei Tang

The ability to simultaneously visualize the presence, abundance, location and functional state of many targets in cells and tissues has been described as a true next-generation approach in immunohistochemistry (IHC). A typical requirement for multiplex IHC (mIHC) is the use of different animal species for each primary (1°Ab) and secondary (2°Ab) antibody pair. Although 1°Abs from different species have been used with differently labeled species-specific 2°Abs, quite often the appropriate combination of antibodies is not available. More recently, sequential detection of multiple antigens using 1°Abs from the same species used a microwaving treatment between successive antigen detection cycles to elute previously bound 1°Ab/2°Ab complex and therefore to prevent the cross-reactivity of anti-species 2°Abs used in subsequent detection cycles. We present here a fully automated 1°Ab/2°Ab complex heat deactivation (HD) method on Ventanas BenchMark ULTRA slide stainer. This method is applied to detection using fluorophore-conjugated tyramide deposited on the tissue and takes advantage of the strong covalent bonding of the detection substrate to the tissue, preventing its elution in the HD process. The HD process was characterized for (1) effectiveness in preventing Ab cross-reactivity, (2) impact on the epitopes and (3) impact on the fluorophores. An automated 5-plex fluorescent IHC assay was further developed using the HD method and rabbit 1°Abs for CD3, CD8, CD20, CD68 and FoxP3 immune biomarkers in human tissue specimens. The fluorophores were carefully chosen and the narrow-band filters were designed to allow visualization of the staining under fluorescent microscope with minimal bleed through. The automated 5-plex fluorescent IHC assay achieved staining results comparable to the respective single-plex chromogenic IHC assays. This technology enables automated mIHC using unmodified 1°Abs from same species and the corresponding anti-species 2°Ab on a clinically established automated platform to ensure staining quality, reliability and reproducibility.


Laboratory Investigation | 2017

Covalently deposited dyes: a new chromogen paradigm that facilitates analysis of multiple biomarkers in situ

William Day; Mark Lefever; Robert L. Ochs; Anne Pedata; Lauren Behman; Julia Ashworth-Sharpe; Donald Johnson; Eric May; James Grille; Esteban Roberts; Jerry W Kosmeder; Larry Morrison

Multiplexed analysis of multiple biomarkers in a tissue sample requires use of reporter dyes with specific spectral properties that enable discrimination of signals. Conventional chromogens with broad absorbance spectra, widely used in immunohistochemistry (IHC), offer limited utility for multiplexed detection. Many dyes with narrow absorbance spectra, eg rhodamines, fluoresceins, and cyanines, potentially useful for multiplexed detection are well-characterized; however, generation of a chromogenic reagent useful for IHC analysis has not been demonstrated. Studies reported herein demonstrate utility of tyramine-chemistry for synthesis of a wide variety of new chromogenic dye conjugates useful for multiplexed in situ analysis using conventional light microscopes. The dyes, useful individually or in blends to generate new colors, provide signal sensitivity and dynamic range similar to conventional DAB chromogen, while enabling analysis of co-localized biomarkers. It is anticipated that this new paradigm will enable generation of a wide variety of new chromogens, useful for both research and clinical biomarker analysis that will benefit clinicians and patients.


Archive | 2007

Haptens, hapten conjugates, compositions thereof and method for their preparation and use

Jerome W. Kosmeder; Mark Lefever; Donald Johnson; Michael Farrell; Zhanna Zhilina; Christopher Bieniarz


Archive | 2011

DETECTING TARGETS USING MASS TAGS AND MASS SPECTROMETRY

Rui Hong; Hong Wang; Mark Lefever; Jan Froehlich; Christopher Bieniarz; Brian D. Kelly; Phillip Miller


Archive | 2011

Hapten conjugates for target detection

Adrian E. Murillo; Jerome W. Kosmeder; Eric May; William Day; Mark Lefever; Anne Pedata; Christopher Bieniarz; Phillip Miller


Archive | 2004

Microwave mediated synthesis of nucleic acid probes

Christopher Bieniarz; Michael Farrell; Jerome W. Kosmeder; Mark Lefever


Archive | 2013

SIGNALING CONJUGATES AND METHODS OF USE

Nelson Alexander; William Day; Jerome W. Kosmeder; Mark Lefever; Larry Morrison; Anne Pedata; Stacey Stanislaw


Bioconjugate Chemistry | 2010

Microwave-mediated synthesis of labeled nucleotides with utility in the synthesis of DNA probes.

Mark Lefever; Jerome W. Kosmeder; Michael Farrell; Christopher Bieniarz


Archive | 2006

Enzymes conjugated to antibodies via a peg heterobifuctional linker

Christopher Bieniarz; Jennifer Wong; Mark Lefever; Jerome W. Kosmeder; Julia Ashworth-Sharpe; Casey A. Kernag


Cancer Research | 2018

Abstract 1600: Expanded multiplexing capability in brightfield immunohistochemistry utilizing multiple chromogen chemistries and detection enzymes

Esteban Roberts; William Day; Brian D. Kelly; Nathan W. Polaske; Julia Ashworth-Sharpe; Donald E. Johnson; Mark Lefever; Jerry W Kosmeder; Hongjun Zhang; Jian Zhang; Tsu-Shuen Tsao; Michael Farrell; Joerg Bredno; Robert L. Ochs; Larry E. Morrison

Collaboration


Dive into the Mark Lefever's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Donald E. Johnson

Southwest Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert L. Ochs

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Brian D. Kelly

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hong Wang

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Larry E. Morrison

Rush University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge